HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

soretolide

structure given in first source

Also Known As:

2,6-dimethylbenzamide-N-(5-methyl-3-isoxazole); D 2916; D2916

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Isoxazoles: 155
      - soretolide: 2

Experts

1.	Fatope, M O: 1 article (06/2001)

Related Diseases

1.	Epilepsy (Aura) 06/01/2001 - "Laboratoires Biocodex is developing soretolide (D-2916) as a potential treatment for epilepsy. " 10/01/1999 - "In this review, we consider the possible physiological targets for anti-epileptic drugs, the animal models of epilepsy, problems with clinical trials and ten promising anti-epileptic drugs in development (AWD 131-138, DP16 (DP-VPA), ganaxolone, levetiracetam, losigamone, pregabalin, remacemide, retigabine, rufinamide and soretolide). "
2.	Seizures (Absence Seizure) 06/01/2001 - "In animal models, soretolide shows an anticonvulsant profile similar to carbamazepine, being active in the maximal electroshock test and poorly active against pentylenetetrazole-induced seizures [299344]. "

Related Drugs and Biologics

1.	Levetiracetam (Keppra)
2.	Pregabalin (Lyrica)
3.	DP-VPA
4.	AWD 131-138
5.	ganaxolone
6.	ezogabine (retigabine)
7.	rufinamide
8.	remacemide
9.	losigame (A033)
10.	Pentylenetetrazole (Metrazol)